Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jun 8:63:418-425.
doi: 10.2340/1651-226X.2024.34138.

Relative risk of second malignant neoplasms highest among young adult cancer patients - a population-based registry study in Finland

Hanna A M Koivisto  1 , Aapeli O Nevala  2 , Joonas M Miettinen  2 , Janne M Pitkäniemi  3 , Nea K Malila  2 , Sanna M M Heikkinen  2
Affiliations

Relative risk of second malignant neoplasms highest among young adult cancer patients - a population-based registry study in Finland

Hanna A M Koivisto et al. Acta Oncol. .

Abstract

Background and purpose: The objective of this study was to explore the incidence of second malignant neoplasms (SMNs) among adult cancer patients in Finland diagnosed with their first primary cancer (FPC) in 1992-2021.

Material and methods: The study used data from the population-based Finnish Cancer Registry (FCR). Risk estimates were calculated using the standardised incidence ratio (SIR), the ratio of observed second cancers compared to the expected numbers assuming the same cancer incidence as the corresponding sex-age-calendar year -split of the general population.

Results: A total of 573,379 FPCs were diagnosed during 1992-2021. During the follow-up, 60,464 SMNs were diagnosed. Male cancer patients had neither a decreased nor an increased risk (SIR 1.00 [95% CI, 0.99-1.01]) and female patients had an 8% increased risk (SIR 1.08 [95% CI, 1.06-1.09]) of developing any SMN compared to a FPC in the general population. The highest SIR of any SMN was observed in patients aged 20-39 -years at FPC diagnosis, and the SIR decreased by increasing age at diagnosis. Patients with lymphoid and haematopoietic tissue neoplasms, cancers of the mouth and pharynx, endocrine glands, respiratory and intrathoracic organs, skin, and urinary organs had the highest SIRs, while patients with cancers of the male genital organs and the female breast had the lowest SIRs.

Interpretation: Elevated SIRs were observed in cancer patients diagnosed at an early age and for FPCs known to be in large part attributable to lifestyle factors, which highlights the importance of monitoring and encouraging lifestyle changes.

PubMed Disclaimer

Conflict of interest statement

The authors report there are no competing interests to declare.

Figures

Figure 1
Figure 1
Forest plot showing the standardised incidence ratios (SIR) and confidence intervals (CI) among men for any metachronous second malignant neoplasm (SMN) diagnosed in Finland between 1992 and 2021 by age at first primary cancer (FPC), diagnosis period of FPC and site of FPC.
Figure 2
Figure 2
Forest plot showing the standardised incidence ratios (SIR) and confidence intervals (CI) among women for any metachronous second malignant neoplasm (SMN) diagnosed in Finland between 1992 and 2021 by age at first primary cancer (FPC), diagnosis period of FPC, and site of FPC.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Sung H, Ferlay J, Siegel RL, et al. . Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 285 countries. CA Cancer J Clin. 2021;71(3):209–49. 10.3322/caac.21660 - DOI - PubMed
    1. Cancer statistics application of the Finnish Cancer Registry [Internet]. Finnish Cancer Registry. [cited 03-2022]. Available from: https://cancerregistry.fi/statistics/cancer-statistics/
    1. Pitkäniemi J, Malila N, Tanskanen T, et al. . Cancer in Finland 2020. Helsinki: Cancer Society of Finland; 2022.
    1. Morton LM, Dores GM, Schonfeld SJ, et al. . Association of chemotherapy for solid tumors with development of therapy-related myelodysplastic syndrome or acute myeloid leukemia in the modern era. JAMA Oncol. 2019;5(3):318–25. 10.1001/jamaoncol.2018.5625 - DOI - PMC - PubMed
    1. Dracham CB, Shankar A, Madan R. Radiation induced second malignancies: a review article. Radiat Oncol J. 2018;26(2):85–94. 10.3857/roj.2018.00290 - DOI - PMC - PubMed

LinkOut - more resources